Abdel-Aleem H, d'Arcangues C, Vogelsong M, et al: Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 10:CD003449, 2013
Abrams LS, Skee OM, Wong FA, et al: Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches. J Clin PharmacoIn41:1232,n2001
Aksoy H, Aksoy U, Ozyurt S, et al: Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double-blind randomised controlled trial. J Fam Plann Reprod Health Care 42(2):83,2016
American College of Obstetricians and Gynecologists: Brand versus generic oral contraceptives. Committee Opinion No. 375, August , Reairmed 2015a American College of Obstetricians and Gynecologists: Emergency contraception. Practice Bulletin No. 152, September 2015b
American College of Obstetricians and Gynecologists: Increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy. Committee Opinion No. 642, October 2015c
American College of Obstetricians and Gynecologists: Adolescents and long-acting reversible contraception: implants and intrauterine devices. Committee Opinion No. 539, October 2012, Reairmed 2016a
American College of Obstetricians and Gynecologists: Depot medroxyprogesterone acetate and bone efects. Committee Opinion No. 602, June 2014, Reairmed 2016b
American College of Obstetricians and Gynecologists: Noncontraceptive use of hormonal contraceptives. Practice Bulletin No. 110, January 2010, Reafirmed 2016c
American College of Obstetricians and Gynecologists: Prevention of deep vein thrombosis and pulmonary embolism. Practice
No. 84, August 2007, Reairmed 2016d
American College of Obstetricians and Gynecologists: Access to emergency contraception. Committee Opinion No. 707, July 2017a
American College of Obstetricians and Gynecologists: Beneits and risks of sterilization. Practice Bulletin No. 133, February 2013, Reairmed 2017b
American College of Obstetricians and Gynecologists: Long-acting reversible contraception: implants and intrauterine devices. Practice Bulletin No. 186, November 2017c
Anttila L, Bachmann G, Hernadi L, et a1: Contraceptive eicacy of a combined oral contraceptive containing ethinyl oestradiol 20 !lg/drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis of four open-label studies. Eur J Obstet Gynecol Reprod BioI 155(2):180,n2011
Aoun J, Dines VA, Stovall OW, et al: Efects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol 123(3):585,n2014
Apter 0, Gemzell-Danielsson K, Hauck B, et al: Pharmacokinetics of two lowdose levonorgestrel-releasing intrauterine systems and efects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Ferti! Steriln101(6):1656,n2014